Suppr超能文献

[非胰岛素依赖型糖尿病肾病患者血浆过氧化脂质和血清超氧化物歧化酶含量的观察]

[Observation on the content of plasma lipoperoxide and serum superoxide dismutase in NIDDM nephrosis patients].

作者信息

Chen X, Liu H, Yi M

机构信息

Fuxing Hospital, Beijing.

出版信息

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1997 Aug;19(4):305-8.

Abstract

OBJECTIVE

In order to explore the changes of MDA, SOD in each period of diabetic nephrosis patients, the contents of MDA and SOD from 40 cases of NIDDM nephrosis patients in various stages and 15 cases of normal persons (control group) were measured.

METHODS

By using method of sulpho-barbiamino acid to determine the concentration of serum MDA (the reagents are provided by Juli Biomedical Engineering Institute of Nanjing). By using method of radioimmunization to determine the concentration of SOD (The reagents are provided by Huaqing Biological Technic Institute of Beijing), blood sugar, T-cho, TG, Bun, Ccr, UAE, etc. in serum were simutaneouslly determined. By adopting statistical method to analyse the mean difference in each groups and the interrelation of each data.

RESULTS

The results show that the content of MDA in each groups exceeds normal control group and the content of MDA of the group of diabetic kidney failure (DKF) exceeds group of diabetic kidney early stage (DKE) obviously (P < 0.01). Only trace of MDA and SOD can be detected in the liquid of peritoneal dialysis in group of DKF. The content of SOD in each groups exceeds normal control group without exception and the content of SOD in group of DKF exceeds that of the group of diabetic kidney function injury stage obviously (P < 0.01).

CONCLUSION

Our results suggest that content of SOD might have some clinical value for the diagnosis and prognosis in NIDDM nephrosis and situation of kidney function injury.

摘要

目的

为探讨糖尿病肾病患者各期丙二醛(MDA)、超氧化物歧化酶(SOD)的变化,检测40例非胰岛素依赖型糖尿病(NIDDM)肾病各期患者及15例正常人(对照组)血清中MDA和SOD的含量。

方法

采用硫代巴比妥酸法测定血清MDA浓度(试剂由南京聚力生物医学工程研究所提供)。采用放射免疫法测定SOD浓度(试剂由北京华清生物技术研究所提供),同时测定血清中的血糖、总胆固醇(T-cho)、甘油三酯(TG)、尿素氮(Bun)、肌酐清除率(Ccr)、尿白蛋白排泄率(UAE)等。采用统计学方法分析各组均值差异及各数据间的相关性。

结果

结果显示,各组MDA含量均高于正常对照组,糖尿病肾衰竭(DKF)组MDA含量明显高于糖尿病肾病早期(DKE)组(P<0.01)。DKF组腹膜透析液中仅检测到微量MDA和SOD。各组SOD含量均高于正常对照组,DKF组SOD含量明显高于糖尿病肾功能损伤期组(P<0.01)。

结论

结果提示,SOD含量对NIDDM肾病及肾功能损伤情况的诊断和预后可能具有一定临床价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验